The National Institutes of Health, several pharmaceutical companies, and non-profit groups have formed a coalition to develop and encourage research into treating diseases including Alzheimer's, rheumatoid arthritis, lupus, and type 2 diabetes.
Pfizer Among Drugmakers in U.S. Chronic Disease Project [Bloomberg]
NIH announces novel venture with drug companies to fight major diseases [Washington Post]
An Unusual Partnership to Tackle Stubborn Diseases [New York Times]